Quit2Heal App for Smoking Cessation in Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It mainly focuses on smoking cessation and the use of specific apps.
Is the Quit2Heal app safe for use in humans?
How is the Quit2Heal app treatment different from other smoking cessation treatments for cancer patients?
The Quit2Heal app is unique because it is specifically designed for cancer patients, addressing issues like cancer-related shame, stigma, depression, and anxiety, while using Acceptance and Commitment Therapy to help users accept cravings without smoking and stay motivated to quit. This app is tailored to the needs of cancer patients, unlike general smoking cessation apps, and aims to be a more effective and accessible option integrated with oncology care.12467
What data supports the effectiveness of the Quit2Heal App treatment for smoking cessation in cancer patients?
The Quit2Heal App is designed specifically for cancer patients and is based on Acceptance and Commitment Therapy, which helps people accept cravings without smoking and stay motivated to quit. A study is testing its effectiveness compared to another app, QuitGuide, to see if it helps more cancer patients quit smoking over 12 months.12489
Who Is on the Research Team?
Jonathan B Bricker
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for adults over 18 in the US who have been diagnosed with cancer within the last two years or are undergoing treatment. Participants must be current smokers interested in quitting, willing to use a smartphone app for cessation, and able to complete surveys. They should not be using other quit-smoking programs or have used NCI's QuitGuide app.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Quit2Heal app or the QuitGuide app and are encouraged to use it frequently
Follow-up
Participants are monitored for smoking cessation at 3, 6, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Quit2Heal Smartphone App
- QuitGuide App
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Research Center
Lead Sponsor
Fred Hutchinson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Memorial Sloan Kettering Cancer Center
Collaborator
American Cancer Society, Inc.
Collaborator